J. Blake Bartlett
- Hematology top 0.5%
- Molecular Biology top 5%
- Oncology top 2%
- Genetics top 2%
- Immunology top 5%
- Co-authors
- Angus DalgleishKeith DredgePeter SchäferDavid StirlingGeorge W. MullerLei WuRoger ChenMary Adams
- Topics
- Multiple Myeloma Research and Treatments (31 papers)Protein Degradation and Inhibitors (21 papers)Cancer Treatment and Pharmacology (10 papers)
- Cited by
- HematologyGeneticsOncology
- Partner nations
- United KingdomSwitzerlandUnited States
In The Last Decade
J. Blake Bartlett
43 papers receiving 2.9k citations
Hit Papers
Peers
Comparison fields: 5 of 99
- Hematology 1.7k
- Molecular Biology 1.6k
- Oncology 1.2k
- Genetics 560
- Immunology 552
Countries citing papers authored by J. Blake Bartlett
This map shows the geographic impact of J. Blake Bartlett's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Blake Bartlett with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Blake Bartlett more than expected).
Fields of papers citing papers by J. Blake Bartlett
This network shows the impact of papers produced by J. Blake Bartlett. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Blake Bartlett. The network helps show where J. Blake Bartlett may publish in the future.
Co-authorship network of co-authors of J. Blake Bartlett
This figure shows the co-authorship network connecting the top 25 collaborators of J. Blake Bartlett. A scholar is included among the top collaborators of J. Blake Bartlett based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. Blake Bartlett. J. Blake Bartlett is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 11 | |
| 3 | 24 | |
| 4 | 137 | |
| 5 | 18 | |
| 6 | 1 | |
| 7 | 120 | |
| 8 | 63 | |
| 9 | 324 | |
| 10 | 31 | |
| 11 | 183 | |
| 12 | The anticancer drug lenalidomide inhibits angiogenesis and metastasis via multiple inhibitory effects on endothelial cell function in normoxic and hypoxic conditions | 2 |
| 13 | 7 | |
| 14 | VEGFr inhibitor YN968D1 xenograft dose response studies against human colon cancer Ls174t and HT29 | 13 |
| 15 | 22 | |
| 16 | 45 | |
| 17 | 225 | |
| 18 | 50 | |
| 19 | 35 | |
| 20 | 123 |
About J. Blake Bartlett
J. Blake Bartlett is a scholar working on Hematology, Oncology and Sensory Systems, having authored 46 papers that have together received 3.0k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (31 papers), Protein Degradation and Inhibitors (21 papers) and Cancer Treatment and Pharmacology (10 papers). The work is most often cited by research in Hematology (1.7k citations), Genetics (560 citations) and Oncology (1.2k citations). J. Blake Bartlett has collaborated with scholars based in United Kingdom, Switzerland and United States. Frequent co-authors include Angus Dalgleish, Keith Dredge, Peter Schäfer, David Stirling, George W. Muller, Lei Wu, Roger Chen, Mary Adams, Ling Lu and Troy Carter. Their work appears in journals such as Journal of Clinical Oncology, Nature reviews. Cancer and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.